Rom Eliaz
Chief Tech/Sci/R&D Officer at Albaad Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
James S. Peliotes | M | 57 |
Albaad Ltd.
Albaad Ltd. Household/Personal CareConsumer Non-Durables Albaad Ltd. manufactures wet wipes and feminine hygiene products. The private company is based in Old Lyme. The CEO of the American company is Dan F. Mesika. | - |
Dan F. Mesika | M | 61 |
Albaad Ltd.
Albaad Ltd. Household/Personal CareConsumer Non-Durables Albaad Ltd. manufactures wet wipes and feminine hygiene products. The private company is based in Old Lyme. The CEO of the American company is Dan F. Mesika. | - |
Efraim Bazia | M | 59 |
Albaad Ltd.
Albaad Ltd. Household/Personal CareConsumer Non-Durables Albaad Ltd. manufactures wet wipes and feminine hygiene products. The private company is based in Old Lyme. The CEO of the American company is Dan F. Mesika. | - |
Markus Green | M | - | 18 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David Platt | M | 71 |
Avanyx Therapeutics, Inc.
Avanyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avanyx Therapeutics, Inc. engages in the development, manufacture and marketing of therapeutic drugs with a focus on glyco-pathology, a specialized field involving understanding the importance of Glycoproteins in biochemistry and progression of diseases. The company is headquartered in Newton, MA | 7 years |
Kenneth A. Tassey | M | 62 | 5 years | |
Anthony Don Squeglia | M | 81 | - | |
Chi-Heng Cheng | M | 47 | 8 years | |
Carl Laurence Lueders | M | 74 |
Avanyx Therapeutics, Inc.
Avanyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avanyx Therapeutics, Inc. engages in the development, manufacture and marketing of therapeutic drugs with a focus on glyco-pathology, a specialized field involving understanding the importance of Glycoproteins in biochemistry and progression of diseases. The company is headquartered in Newton, MA | 4 years |
Dale Conaway | M | 69 |
Avanyx Therapeutics, Inc.
Avanyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avanyx Therapeutics, Inc. engages in the development, manufacture and marketing of therapeutic drugs with a focus on glyco-pathology, a specialized field involving understanding the importance of Glycoproteins in biochemistry and progression of diseases. The company is headquartered in Newton, MA | 7 years |
Henry Jemil Esber | M | 86 |
Avanyx Therapeutics, Inc.
Avanyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avanyx Therapeutics, Inc. engages in the development, manufacture and marketing of therapeutic drugs with a focus on glyco-pathology, a specialized field involving understanding the importance of Glycoproteins in biochemistry and progression of diseases. The company is headquartered in Newton, MA | 7 years |
Dennis Ausiello | M | 78 | 13 years | |
Alan Hoberman | M | 71 | 3 years | |
Jacob M. Plotsker | M | 56 | 16 years | |
Peter Corr | M | 76 | 6 years | |
Yi Ning Zhao | M | 53 | 8 years | |
Sydney Colin Neill | M | 77 | 6 years | |
Michael R. Jirousek | M | 65 | 5 years | |
Alexander Fowkes | M | - | 5 years | |
Caleb DesRosiers | M | 51 | 2 years | |
Thomas Liquard | M | 51 | 4 years | |
David J. Wustrow | M | 65 | 2 years | |
Antony Loebel | M | 64 | 1 years | |
Rajiv Sarman Shukla | M | 49 | 5 years | |
Sandra Rogers | F | 58 | 4 years | |
Edward Shea | M | - | - | |
Raymond Urbanski | M | 64 | 8 years | |
Nicole Stikeleather | F | - | 5 years | |
Michael Pastoor | M | - | 5 years | |
Thomas Anderson | M | - | 6 years | |
Joan Sellers | M | - | - | |
James T. VanderLugt | M | - | - | |
Barbara Wirostko | M | 58 | 4 years | |
Anna Levander | F | 47 | 3 years | |
Yvonne R. Jackson | F | 74 | 3 years | |
Louise Gelinas | F | - | - | |
Tomasz H. Zastawny | M | - | 3 years | |
Muriel Cottard | M | - | 4 years | |
Margaret Marshall | M | 67 | 8 years | |
Bruce Curtis Crosby | M | - | 2 years | |
Brian Krex | M | 57 | 9 years | |
Daniel Karp | M | 46 | 12 years | |
William S. Korinek | M | - | 9 years | |
Nenad Sarapa | M | - | 6 years | |
Valerie L. Legagneur | F | 50 | 10 years | |
Viviane Monges | F | 60 | 5 years | |
Martin Brodbeck | M | 51 | 3 years | |
John Tilton | M | 56 | 1 years | |
Lee Golden | M | 56 | 4 years | |
William Pringle | M | 56 | 6 years | |
W. Richey Neuman | M | - | 5 years | |
Douglas Milanes | M | 61 | 7 years | |
Scott Cheshareck | M | - | 16 years | |
Jan Brinkman | M | 62 | 2 years | |
Eric Hoberman | M | - | 1 years | |
Jonathan B. Rome | M | 68 | 1 years | |
Andreas Fibig | M | 62 | 2 years | |
Fei He | M | 55 | 7 years | |
Jennifer J. Rhodes | F | 53 | 6 years | |
Benjamin Rivnay | M | - | - | |
Wesley W. Day | M | 59 | 12 years | |
Brian Goldberg | M | 50 | 2 years | |
Anthony Principi | M | 80 | 6 years | |
Jean-Paul Vallès | M | - | 25 years | |
Stanley O. Ikenberry | M | 88 | 2 years | |
Franklin Raines | M | 74 | 7 years | |
Claus Egstrand | M | 63 | 3 years | |
Marc Robinson | M | 63 | 6 years | |
Janet L. Conway | M | 74 | 2 years | |
Kenneth Bahrt | M | 71 | 4 years | |
Philip D. Worboys | M | 54 | 2 years | |
Jon Coleman | M | 60 | 12 years | |
Pierre F. Dodion | M | 69 | 1 years | |
James L. Freddo | M | 69 | 3 years | |
Siegfried Reich | M | 64 | 4 years | |
Meghan Fitzgerald | M | 53 | 5 years | |
Robert Karr | M | 75 | 4 years | |
Mark W. Pierce | M | 75 | 3 years | |
Nancy Hutson | M | 74 | 25 years | |
Eduardo Von Pervieux | M | - | 6 years | |
Suhail Nurbhai | M | - | 12 years | |
Francesco Granata | M | 73 | 2 years | |
Brian Esser | M | - | 3 years | |
Daniel Cronin | M | 78 | - | |
Ngozi Edozien | F | 59 | 6 years | |
Lauren Silverman | M | 69 | 5 years | |
Jay Olson | M | - | 16 years | |
Rolf Kletzien | M | - | - | |
James Symons | M | - | - | |
George W. Evans | M | 70 | 26 years | |
Gary Seelhorst | M | 53 | 8 years | |
Kishore Ganji | M | - | 1 years | |
Michael Cooper Pearce | M | 62 | 5 years | |
Patrick Lu | M | 68 |
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | 6 years |
Philip Haworth | M | 68 |
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | - |
Yoshihiro Toyohara | M | - | 2 years | |
Navin Jacob | M | - | 3 years | |
Sharon Real | M | 60 | 6 years | |
Bonne Adams | F | 47 | 2 years | |
Christopher Verni | M | 49 | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Rom Eliaz
- Personal Network